The acetazolamide (ACZ) test is performed to evaluate the decrease in
cerebral perfusion pressure (CPP) by investigation of vasomotor reacti
vity (VMR), Our aim was to study cerebral blood flow and blood volume
changes induced by the ACZ test in healthy control subjects using dyna
mic susceptibility contrast-enhanced gradient-echo MRI (DSC-MRI), A FL
ASH sequence was used to produce susceptibility-weighted images during
an intravenous injection of 0.1 mmol/kg gadopentetate dimeglumine (Gd
-DTPA). After the first dynamic study, 1g acetazolamide was given intr
avenously and 10 min later a second bolus of Gd-DTPA, was injected, Us
ing the indicator-dilution theory, relative cerebral blood volume and
relative cerebral blood flow were estimated. In healthy subjects the A
CZ test induced a significant increase in relative blood volume (from
80.5 +/- 10.7 to 113.4 +/- 11.9) and relative blood flow (from 5.73 +/
- 0.96 to 7.5 +/- 0.97), symmetrically in the cerebral hemispheres. Th
is approach might be promising in the understanding of cerebral haemod
ynamics in patients with vascular disorders.